Dist. companies against pharma. dist. margin cuts caused by high margins on CSOs

It was criticized in the distribution industry that while some pharmaceutical companies are constantly planning to reduce pharmaceutical distribution companies’ margins, they have still provided high margins for CSO companies.

Particularly, the pharmaceutical distribution industry has concerned their position might be minimized by pharmaceutical companies that are actively using CSOs.

Accordi...